CannaLean has established an active partnership with a main shareholders-
Mor Research Applications, the tech transfer company of CLALIT HEALTH SERVICES.

CLALIT is thelargest HMO in Israel, with over 4.5M members.
It operates 14 full scale hospitals specializing in all fields of medicine, as well as over 2000 community clinics with over 9000 employed physicians.

Mor Research Applications was established in 1994, as the Technology Transfer Unit of CHS.
To date, Mor has handled over 300 patent applications and has established over 50 portfolio start-up companies, in diverse fields of pharmaceuticals, medical devices, diagnostics, digital health and more.

This strategic partnership allows CannaLean to enjoy close proximity to Israel’s leading research and clinical centers, direct access to collaboration with leading KOLs and physicians in diverse medical fields and an insider’s look into one of Israel’s leading innovation and IP generation centers in the medical field.

The Mor & CannaLean partnership allows us to maximize the potential and to reach vast numbers of patients and data.